An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) (REVIVE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2013 by Vericel Corporation.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Vericel Corporation Identifier:
First received: November 30, 2011
Last updated: July 17, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)